Thus, all the evidence gathered so far point to the importance of dysregulation of the NKG2D/NKG2DL axis in tumor cell escape and growth, suggesting that restoration of a correct immune surveillance may represent a novel immunotherapeutic approach for HCC (Figure 1). Here, KLRK1 is linked to hepatocellular carcinoma.